NCT00805480View on ClinicalTrials.gov

Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Chronic Plaque Psoriasis
Interventions
DRUG

AIN457

AIN457 was administered intravenously.

DRUG

Placebo

Matching placebo to AIN457 was administered intravenously.

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY